Login / Signup

Yet another in vitro evidence that natural compounds introduced by diet have anti-amyloidogenic activities and can counteract neurodegenerative disease depending on aging.

Anna Lia AstiStefania CrespiTeresa RampinoPaola ZeliniMarilena GregoriniAlessia PascaleNicoletta MarchesiStefania SaccucciCarla ColombaniSara VitaliniMarcello Iriti
Published in: Natural product research (2023)
A major issue in Alzheimer's disease (AD) research is to find some new therapeutic drug which decrease Amyloid-beta (Aβ) aggregation. From a therapeutic point of view the major question is whether pharmacological inhibition of inflammation pathways will be able to safely reverse or slow the course of disease. Natural compounds are capable of binding to different targets implicated in AD and exert neuroprotective effects. Aim of this study was to evaluate the in vitro inhibition of Aβ 1-42 fibrillogenesis in presence of Gallic acid, Rutin, Melatonin and Provinols TM . We performed the analysis with Transmission and Scanning Electron Microscopy, and with X-ray microanalysis. Samples treated with Rutin, that arises from phenylalanine via the phenylpropanoid pathway, show the best effective result obtained because a significantly fibril inhibition activity is detectable compared to the other compounds. Melatonin shows a better inhibitory activity than Provinols TM and Gallic acid at the considered concentrations.
Keyphrases
  • electron microscopy
  • physical activity
  • oxidative stress
  • emergency department
  • magnetic resonance imaging
  • computed tomography
  • weight loss
  • cognitive decline
  • magnetic resonance
  • adverse drug